{"name":"Kiniksa Pharmaceuticals (UK), Ltd.","slug":"kiniksa-pharmaceuticals-uk-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KPL-914","genericName":"KPL-914","slug":"kpl-914","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"KPL-914","genericName":"KPL-914","slug":"kpl-914","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPalU2aW00Y1JJRVhTQVE2ZnlzNTV1Vzk1U2tJaVVDUFdncVBjOTdqWE1LY1JJQ19IQjd1amtybnRZSHhwanRBcG1XeUtadm1NSnB6U29EMjlDTXBqenBRRVJLMG9mY2Y0b0gxSU5fLTdfVnVEN1dRTTRUZ3FZUm9yZ095bzNNU1pwWkpzeUo1Yw?oc=5","date":"2025-07-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Sanofi concludes Blueprint Medicines acquisition - Pharmaceutical Technology","headline":"Sanofi concludes Blueprint Medicines acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxQSDRlcTFteFU3MEkzSnNQdTRXV2RZMTZ4RGk1ZTkyblltZTI1SDBBWjkzUnhNVmpTRkM1dDk0YnA3VWlJcVZnQ0pMMllPQ3RkOENmYkRxYldTcVpLQkh6ZEYxWUVUSlNXWVZsS3ZnazZRR3BzSllPNUFvM1hTRXdudjZacm91QkFGWkluWlZOdThaLUpXU2QwVS1JV0dzdFZndVJHVHdEMVJ6UkpxVUUwUFdXRENxLUtOTjdSMGdqWHdrNUkwVTBPdjlQazB5Z3hjTktIbXROcmt0Uk5XNThfVnRYVF9KQlY2bVhCUW5sRGdXUVdiTE9pdGFVRy0xVVliNjNMZFRfblpfVkdsSENjQ2RLdThzczQ?oc=5","date":"2025-03-04","type":"regulatory","source":"PR Newswire UK","summary":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight - PR Newswire UK","headline":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOZkNhSjJwaE1zbnpUaEVYSnhEZ3pDSk5aaWVOM01DVUprQTRSN0wwdEw2bElLMFdxTkNIRXQ0LWZLRVNOdHE4dHVZV0poLXI3OEp6Q2tORlBDNDhNbk8ybzVpcnVUUUV4Zkg0QTNXelJyekNXc3NLOTlfZ2U2eTNCWnlBWkpCanRMSkZiaWxJWWh0SFRCZ2E4?oc=5","date":"2025-03-02","type":"deal","source":"Yahoo Finance","summary":"Is Kiniksa Pharmaceuticals International, plc (KNSA) the Best Small Cap Pharma Stock to Buy Now? - Yahoo Finance","headline":"Is Kiniksa Pharmaceuticals International, plc (KNSA) the Best Small Cap Pharma Stock to Buy Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPdlhncUlBQW5sS01qeG96TTRPdmdubFBMRG1SQnY1ZnZOQjFhMjFld19ibGpXYXI3OVZRNlRLM0Z3Tlo1U0ozY1hHdmtWaWc5RW9iLWY4aVV5WGh6YmFwLWpOUEVON1dZeC04UHdfcTNNWmVkNEV6ZXBKZmFETG1SRklaaGo?oc=5","date":"2025-02-26","type":"pipeline","source":"The Pharma Letter","summary":"Kiniksa slims focus to cardiovascular diseases - The Pharma Letter","headline":"Kiniksa slims focus to cardiovascular diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPS3V5b1RXcFZzUHVoX1VpN3JXanBYNVBsZjBPLVRiS2JVWllkWlFrYkdHUXBoS0VUejFFWjF3NmNsMks3eGZIYy1UMjVPeUNWU01UeDlPUjVQZFBHS29KQXFFVmNqM1RGbElBaUtJOFZfV2xlX2Nsb2RUel84M2NhR2FqNmd1dDhxUGwwOE1pY2VyUnhuSmszRkN5d19FM051a25HV1BPMEw2Zw?oc=5","date":"2024-06-28","type":"pipeline","source":"Investing.com UK","summary":"Kiniksa Pharmaceuticals shifts incorporation to UK - Investing.com UK","headline":"Kiniksa Pharmaceuticals shifts incorporation to UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOeTgyUVFxalVIS3o1dlN5SEZ4cXFsc3dSaS1FakxySGtUdVk5WUZ3cEs5bnNXdVgtZWRjRW1MM3pidUdZdHpPSy1ma1A2MEFPaGc1bDdlY29nVnRmemlzRmpOZENaZ2l0VXhKMHBHSzVUMVlkSGppN19ldi0zSHZrRlh0dzJaYm5fQnNscFhLaW5pNjBRUGx0MkJjYTZYbWwzR2NMdi05UDJoblJ2dEZMLXlrLUFBYnpFaHhneDFqdS1oN2JDTjhr?oc=5","date":"2024-04-22","type":"pipeline","source":"Royal Gazette | Bermuda","summary":"Kiniksa shareholders’ meeting to be held on June 5 - Royal Gazette | Bermuda","headline":"Kiniksa shareholders’ meeting to be held on June 5 - Royal Gazette | Bermuda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPR18tMm9Mb3J0TDVOZjVlNjQtbHRMblhraGpQZ1FKeWlqMDQ2SDJtbGE5V2puQVVMRExiazk5b1BYM2xpZ3dfTWlfcWp1YXJxUUc3MHRuOExUcGlfMy1QR21JR1Ffb2FSS1lYOXNZUDhiWG5OcGJUNmluRWVEM1kwbUt0UzZwNzZxM1VhUEw3OVkyWlRGV1RoQkZhQzhCTWVLVDlNUUhkTV9PdnFIZk9TLV9VY0NUaDVGLURBVk5QMGZHcmVFYXdWTU5KbTZ6OV9oUHduZ1dWTjN0S255Vnc2WTNNcGM?oc=5","date":"2024-04-08","type":"pipeline","source":"PR Newswire","summary":"Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight - PR Newswire","headline":"Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPYXFwZ3BwV3JmVkVSakFUUnpaQVhFcFdseXlEY3RIUUdTMFVlaC1HR0RuQkhYSDYzQW1UcGU3R2pHOGZOUHhKUjdtQ3FPQzcwY1VVLWJPOUFjZUdkS3FVSExlRUJmdlNaZHJTNDB1bktlMHVwQ04xdnoxQTI5WWg2MnJ1UmZ5NGUxMnVqbS13dzdKdUZ5RlZNS2xoWVVRWmpPRTBpbUZLMF9SVVFXYWRJeXlZYkRqd2NBXzV0OE9wU1p4YXM1enVtbl9zRElqQjhpX0swUldGcy0xTlRXbU5lbG9HeXhreEg3elllYW1Hc2RSY3pTU3ZWWEVIYWE1NV90Uld3X05vbXQ?oc=5","date":"2022-07-26","type":"pipeline","source":"PR Newswire","summary":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight - PR Newswire","headline":"New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxPWnZUNGh4Z0hkbmZuVEhvVjZuU29RWXVWOW5yaW42UnluaXo1MVBCNjdkUUEtTXVFMW1EX2dVaTJBLXFHZDNHUC1UOWYwcllfZzNsQVdtQjg5TjdNYWNaemRmM1F4WGVFak10dWFwTXhTc3V4RjhOOUEwMjlaSmJMYVV3RDl0UmdLUlczTUV2TjhVUHhURHFobjN2MUZhVy1Jb19YN0lDbFZQUk43bldYcG8zQVVERTRpNV93MjdnYWdSaFR4ZWZkREtFTW5UQm9UdlJEaXlJNDNhOXdfTXpTMGxPbTE3d1lMeDYzWkR2bEdpb3FZaVYtRmdxeFphN1hZc0V3N3FESlFiUG1VWEdNOVZKZV9nWW9jODc1MUs0R0pZWGxhVGZrTFhPSDJyZw?oc=5","date":"2022-04-25","type":"trial","source":"PR Newswire","summary":"Chronic Spontaneous Urticaria Market Is Anticipated to Progress at a CAGR of 14.96% in the 7MM for the Study Period of 2019-32, Estimates DelveInsight - PR Newswire","headline":"Chronic Spontaneous Urticaria Market Is Anticipated to Progress at a CAGR of 14.96% in the 7MM for the Study Period of 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBjeW9zNndNU05OdnhQQVd3ZExEMUNSRlFOWXQ1Z19mUGhYQXUwMzlhdEQ1MGN0eXQ5ak1ndTVVUVZxbzBtb0tZR190alg1YXFs?oc=5","date":"2021-09-14","type":"pipeline","source":"The Motley Fool","summary":"Kiniksa Pharmaceuticals International, Plc - KNSA - Stock Price & News - The Motley Fool","headline":"Kiniksa Pharmaceuticals International, Plc - KNSA - Stock Price & News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE1EU1VQOXd5a3RXdzI3RW9aNFl3QkNFRzBXaTBaZVFvcTFNZFpWeUhCLW0xSjJvUFdrT2NOR0xHcUh0aG9Ua0IxNA?oc=5","date":"2020-12-01","type":"deal","source":"StockInvest.us","summary":"Kiniksa Pharmaceuticals . Class A Stock Price Forecast. Should You Buy KNSA? - StockInvest.us","headline":"Kiniksa Pharmaceuticals . Class A Stock Price Forecast. Should You Buy KNSA?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE93eGduVFVyNV9uMUpzajc0ZVhLVzMyR1ZTNFlMcEZMSmdTX3Q2cGpnUVBMT19wS1pSX3Axb3IwbmxiU0Z6SE84TjZvM2E1cmJyZ3c?oc=5","date":"2020-06-23","type":"pipeline","source":"Yahoo Finance UK","summary":"Kiniksa Pharmaceuticals International, plc (KNSA) stock price, news, quote and history - Yahoo Finance UK","headline":"Kiniksa Pharmaceuticals International, plc (KNSA) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}